A carregar...
18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)
BACKGROUND: (18)F‐flutemetamol uptake by brain tissue, measured by positron emission tomography (PET), is accepted by regulatory agencies like the Food and Drug Administration (FDA) and the European Medicine Agencies (EMA) for assessing amyloid load in people with dementia. Its added value is mainly...
Na minha lista:
| Publicado no: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Ltd
2017
|
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6486287/ https://ncbi.nlm.nih.gov/pubmed/29164602 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012884 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|